Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women
Stephen Paul Avvaru, Shyam S. Shukla(Centre for Air Borne System), Malleshappa N. Noolvi, Sudipta Chkraborty(Bhabha Atomic Research Centre), Ashutosh Dash(Bhabha Atomic Research Centre), Tejraj M. Aminbhavi
Cited by 26
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Electrode materials for lithium-ion batteries
|Materials Science for Energy Technologies|2018|165
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117